Literature DB >> 17667217

Chloroquine-induced recurrent psychosis.

Saddichha Sahoo1, Manoj Kumar, Vinod K Sinha.   

Abstract

Chloroquine is a commonly prescribed antimalarial drug that is widely used for the presumptive treatment of malaria in India. It has rarely been reported to cause psychosis, and to the best of our knowledge, recurrent psychosis due to chloroquine use has been reported only once, in 1996. We are reporting the second case of chloroquine-induced recurrent psychosis. We also discuss some of the possible neurobiological mechanisms leading to this neurotoxic adverse effect and our recommendations for future use of this drug.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17667217     DOI: 10.1097/MJT.0b013e31802e4b0e

Source DB:  PubMed          Journal:  Am J Ther        ISSN: 1075-2765            Impact factor:   2.688


  9 in total

Review 1.  Safety of Short-Term Treatments with Oral Chloroquine and Hydroxychloroquine in Patients with and without COVID-19: A Systematic Review.

Authors:  Sergio Marin; Alba Martin Val; Maite Bosch Peligero; Cristina Rodríguez-Bernuz; Ariadna Pérez-Ricart; Laia Vilaró Jaques; Roger Paredes; Josep Roca; Carles Quiñones
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-21

Review 2.  Understanding the clinical spectrum of complicated Plasmodium vivax malaria: a systematic review on the contributions of the Brazilian literature.

Authors:  Marcus V G Lacerda; Maria P G Mourão; Márcia A A Alexandre; André M Siqueira; Belisa M L Magalhães; Flor E Martinez-Espinosa; Franklin S Santana Filho; Patrícia Brasil; Ana M R S Ventura; Mauro S Tada; Vanja S C D Couto; Antônio R Silva; Rita S U Silva; Maria G C Alecrim
Journal:  Malar J       Date:  2012-01-09       Impact factor: 2.979

Review 3.  Psychiatric effects of malaria and anti-malarial drugs: historical and modern perspectives.

Authors:  Remington L Nevin; Ashley M Croft
Journal:  Malar J       Date:  2016-06-22       Impact factor: 2.979

4.  Prolonged neuropsychiatric effects following management of chloroquine intoxication with psychotropic polypharmacy.

Authors:  Nicole M Maxwell; Remington L Nevin; Stephen Stahl; Jerald Block; Sarah Shugarts; Alan H B Wu; Stephen Dominy; Miguel Alonso Solano-Blanco; Sharon Kappelman-Culver; Christopher Lee-Messer; Jose Maldonado; Andrew J Maxwell
Journal:  Clin Case Rep       Date:  2015-04-09

Review 5.  Therapeutic use of chloroquine and hydroxychloroquine in COVID-19 and other viral infections: A narrative review.

Authors:  Anwar M Hashem; Badrah S Alghamdi; Abdullah A Algaissi; Fahad S Alshehri; Abdullah Bukhari; Mohamed A Alfaleh; Ziad A Memish
Journal:  Travel Med Infect Dis       Date:  2020-05-06       Impact factor: 6.211

6.  Psychosis consequent to antimalarial drug use in a young child.

Authors:  Jitender Aneja; Dheeraj Goya; Bharat Choudhary
Journal:  J Family Med Prim Care       Date:  2019-05

Review 7.  Management of Neuropsychiatric Systemic Lupus Erythematosus: Current Approaches and Future Perspectives.

Authors:  César Magro-Checa; Elisabeth J Zirkzee; Tom W Huizinga; Gerda M Steup-Beekman
Journal:  Drugs       Date:  2016-03       Impact factor: 9.546

8.  COVID-19 patients managed in psychiatric inpatient settings due to first-episode mental disorders in Wuhan, China: clinical characteristics, treatments, outcomes, and our experiences.

Authors:  Qin Xie; Fang Fan; Xue-Peng Fan; Xiao-Jiang Wang; Ming-Jian Chen; Bao-Liang Zhong; Helen Fung-Kum Chiu
Journal:  Transl Psychiatry       Date:  2020-10-02       Impact factor: 6.222

9.  Psychiatric side effects of chloroquine in COVID-19 patients: two case reports.

Authors:  Roukaya Benjelloun; Yassine Otheman; Chafik El Kettani
Journal:  Pan Afr Med J       Date:  2020-06-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.